CN104651310A - 一种体外诱导扩增nk细胞的方法 - Google Patents
一种体外诱导扩增nk细胞的方法 Download PDFInfo
- Publication number
- CN104651310A CN104651310A CN201510090232.5A CN201510090232A CN104651310A CN 104651310 A CN104651310 A CN 104651310A CN 201510090232 A CN201510090232 A CN 201510090232A CN 104651310 A CN104651310 A CN 104651310A
- Authority
- CN
- China
- Prior art keywords
- cell
- radix
- lemna paucicostata
- external evoked
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000822 natural killer cell Anatomy 0.000 title claims abstract description 95
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000003321 amplification Effects 0.000 title claims abstract description 25
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 25
- 238000000338 in vitro Methods 0.000 title abstract description 6
- 210000004027 cell Anatomy 0.000 claims abstract description 54
- 239000000284 extract Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000004113 cell culture Methods 0.000 claims abstract description 8
- 125000001033 ether group Chemical group 0.000 claims abstract description 5
- 239000003208 petroleum Substances 0.000 claims abstract description 5
- 244000242291 Lemna paucicostata Species 0.000 claims description 60
- 210000005087 mononuclear cell Anatomy 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 16
- 230000000763 evoking effect Effects 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 210000005259 peripheral blood Anatomy 0.000 claims description 8
- 239000011886 peripheral blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 239000012930 cell culture fluid Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000000638 solvent extraction Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 4
- 238000003306 harvesting Methods 0.000 claims description 4
- 229920000669 heparin Polymers 0.000 claims description 4
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 claims description 4
- 229960001008 heparin sodium Drugs 0.000 claims description 4
- 210000002751 lymph Anatomy 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000002504 physiological saline solution Substances 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 3
- 230000002147 killing effect Effects 0.000 abstract description 14
- 230000028327 secretion Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 22
- 230000004663 cell proliferation Effects 0.000 description 17
- 238000010586 diagram Methods 0.000 description 12
- 102000001398 Granzyme Human genes 0.000 description 7
- 108060005986 Granzyme Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- 101001023379 Homo sapiens Lysosome-associated membrane glycoprotein 1 Proteins 0.000 description 4
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 4
- 102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 description 4
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000010100 anticoagulation Effects 0.000 description 3
- 239000002458 cell surface marker Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 2
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 201000000498 stomach carcinoma Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000002091 Febrile Seizures Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000687941 Salvia przewalskii Species 0.000 description 1
- 235000008202 Salvia przewalskii Nutrition 0.000 description 1
- 230000006044 T cell activation Effects 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004721 adaptive immunity Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229940082150 encore Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical group O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 206010016284 febrile convulsion Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229930192851 perforin Natural products 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
实施例 | 三叶青提取物种类 | 提取物浓度 |
实施例8 | 三叶青总提取物(Th-t) | 9.76μg/ml |
实施例9 | 三叶青总提取物(Th-t) | 0.15μg/ml |
实施例10 | 三叶青总提取物(Th-t) | 2.44μg/ml |
实施例11 | 三叶青总提取物(Th-t) | 0.62μg/ml |
实施例12 | 三叶青提取物(Th-p) | 0.62μg/ml |
实施例13 | 三叶青提取物(Th-p) | 2.44μg/ml |
实施例14 | 三叶青提取物(Th-p) | 9.76μg/ml |
实施例15 | 三叶青提取物(Th-p) | 0.01μg/ml |
实施例16 | 三叶青提取物(Th-w2) | 0.166μg/ml |
实施例17 | 三叶青提取物(Th-w2) | 2.44μg/ml |
实施例18 | 三叶青提取物(Th-w2) | 0.155μg/ml |
实施例19 | 三叶青提取物(Th-w2) | 9.76μg/ml |
实施例20 | 三叶青提取物(Th-w3) | 0.0025μg/ml |
实施例21 | 三叶青提取物(Th-w3) | 0.62μg/ml |
实施例22 | 三叶青提取物(Th-w3) | 0.039μg/ml |
实施例23 | 三叶青提取物(Th-w3) | 2.44μg/ml |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510090232.5A CN104651310B (zh) | 2015-02-28 | 2015-02-28 | 一种体外诱导扩增nk细胞的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510090232.5A CN104651310B (zh) | 2015-02-28 | 2015-02-28 | 一种体外诱导扩增nk细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104651310A true CN104651310A (zh) | 2015-05-27 |
CN104651310B CN104651310B (zh) | 2017-10-10 |
Family
ID=53242958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510090232.5A Expired - Fee Related CN104651310B (zh) | 2015-02-28 | 2015-02-28 | 一种体外诱导扩增nk细胞的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104651310B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105255828A (zh) * | 2015-10-31 | 2016-01-20 | 江苏善之源健康科技有限公司 | 一种用于提高cik细胞增殖速率的提取物制备方法 |
CN106421184A (zh) * | 2016-09-27 | 2017-02-22 | 浙江博纳生物科技有限公司 | 三叶青提取物在制备肿瘤免疫治疗药物及人γδT细胞增殖剂中的应用 |
CN106479974A (zh) * | 2016-10-31 | 2017-03-08 | 浙江博纳生物科技有限公司 | 一种三叶青提取物体外诱导扩增人cd3ak细胞的方法和用途 |
CN106520901A (zh) * | 2017-01-15 | 2017-03-22 | 浙江博纳生物科技有限公司 | 研究三叶青提取物提高人共刺激t细胞增殖的方法 |
CN106591233A (zh) * | 2016-12-28 | 2017-04-26 | 广州沙艾生物科技有限公司 | 一种免疫细胞的体外诱导扩增和冻存的方法 |
CN106701681A (zh) * | 2016-12-28 | 2017-05-24 | 广州沙艾生物科技有限公司 | 一种免疫细胞的体外诱导扩增、冻存和复苏的方法 |
CN107779434A (zh) * | 2016-08-30 | 2018-03-09 | 天津市康婷生物工程有限公司 | 高效扩增人外周血nk细胞的实验方法 |
CN115261319A (zh) * | 2022-08-30 | 2022-11-01 | 溯玄(上海)生物技术有限公司 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417000A (zh) * | 2008-09-11 | 2009-04-29 | 宁波保税区欣诺生物技术有限公司 | 一种制备三叶青提取物的新方法 |
-
2015
- 2015-02-28 CN CN201510090232.5A patent/CN104651310B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417000A (zh) * | 2008-09-11 | 2009-04-29 | 宁波保税区欣诺生物技术有限公司 | 一种制备三叶青提取物的新方法 |
Non-Patent Citations (2)
Title |
---|
徐彩菊 等: "中药三叶青提取物抗肿瘤机制初探", 《中国卫生检验杂志》 * |
钟晓明 等: "三叶青提取物对烫伤大鼠肠道局部和全身免疫功能的影响", 《中药材》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105255828A (zh) * | 2015-10-31 | 2016-01-20 | 江苏善之源健康科技有限公司 | 一种用于提高cik细胞增殖速率的提取物制备方法 |
CN107779434A (zh) * | 2016-08-30 | 2018-03-09 | 天津市康婷生物工程有限公司 | 高效扩增人外周血nk细胞的实验方法 |
CN106421184A (zh) * | 2016-09-27 | 2017-02-22 | 浙江博纳生物科技有限公司 | 三叶青提取物在制备肿瘤免疫治疗药物及人γδT细胞增殖剂中的应用 |
CN106479974A (zh) * | 2016-10-31 | 2017-03-08 | 浙江博纳生物科技有限公司 | 一种三叶青提取物体外诱导扩增人cd3ak细胞的方法和用途 |
CN106591233A (zh) * | 2016-12-28 | 2017-04-26 | 广州沙艾生物科技有限公司 | 一种免疫细胞的体外诱导扩增和冻存的方法 |
CN106701681A (zh) * | 2016-12-28 | 2017-05-24 | 广州沙艾生物科技有限公司 | 一种免疫细胞的体外诱导扩增、冻存和复苏的方法 |
CN106520901A (zh) * | 2017-01-15 | 2017-03-22 | 浙江博纳生物科技有限公司 | 研究三叶青提取物提高人共刺激t细胞增殖的方法 |
CN115261319A (zh) * | 2022-08-30 | 2022-11-01 | 溯玄(上海)生物技术有限公司 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
CN115261319B (zh) * | 2022-08-30 | 2023-08-18 | 广东齐美生命医学技术研究院 | 一种多肽诱导扩增的nk细胞及用于细胞治疗的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN104651310B (zh) | 2017-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104651310A (zh) | 一种体外诱导扩增nk细胞的方法 | |
Zhu et al. | Comparisons on enhancing the immunity of fresh and dry Cordyceps militaris in vivo and in vitro | |
WO2018120683A1 (zh) | 一种多组分注射液 | |
CN114874984B (zh) | 一种采用植物提取物体外诱导扩增nk细胞的方法 | |
CN107722131B (zh) | 一种具有显著辅助抗肿瘤活性的全灵芝孢子粉精制多糖及其制备方法和应用 | |
CN106497875A (zh) | 千金藤碱的应用以及一种扩增胎盘造血干细胞的培养基和方法 | |
CN106421184A (zh) | 三叶青提取物在制备肿瘤免疫治疗药物及人γδT细胞增殖剂中的应用 | |
CN113288831B (zh) | 灵芝和/或人参在制备抗炎症因子产品方面的用途及其护肤品或化妆品 | |
CN108102928B (zh) | 一株银杏内生真菌及其应用 | |
CN102755512A (zh) | 一种提高cik细胞增殖速率的中药提取物及其制备方法和应用 | |
CN109939106B (zh) | 驱虫斑鸠菊中分离的倍半萜类化合物在制备治疗白癜风的药物中的用途 | |
CN110179814B (zh) | 一种蝉花虫草多糖、制备方法及在制备预防肾间质纤维化药物中应用 | |
CN103860574B (zh) | 槲皮苷在制备人γδT细胞增殖剂中的应用 | |
CN114949034B (zh) | 东紫苏提取物在制备防治急性肺炎药物中的应用 | |
CN105796587A (zh) | 竹茹多糖在免疫调节、抗肿瘤中的应用 | |
CN110183418A (zh) | 一类山胡椒植物根来源的倍半萜及其分离方法和应用 | |
CN104945460A (zh) | 一种刺梨酸的制备方法及其应用 | |
CN109528744A (zh) | 龙胆苦苷及其应用 | |
CN101766662B (zh) | 一种高效浓缩虫草菌丝体的工艺 | |
KR101097799B1 (ko) | 면역활성이 증진된 구멍갈파래 추출물의 제조방법 | |
CN110776409B (zh) | 一种印度黄檀的提取方法及提取物在抗肿瘤药物中的应用 | |
CN114146124A (zh) | 茶枝柑胎多甲氧基黄酮类化合物在制备抗氧化剂中的应用 | |
CN103113196B (zh) | 一种连钱草酚及其制备方法和应用 | |
CN111150752A (zh) | 鸡骨草提取物在制备抗癌药物中的应用 | |
CN102361644A (zh) | 锡生藤提取物的抗登革热活性 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160729 Address after: 310012 No. 388 Tong Road, Xihu District, Zhejiang, Hangzhou, Yuhang Applicant after: Chen Jinyang Address before: Hangzhou City, Zhejiang province 310000 Shangcheng District Qiutao Road No. 248 Qiutao development building block B Applicant before: HANGZHOU ZHONGDE BEIER BIOTECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20170810 Address after: 310052, Zhejiang, Hangzhou Binjiang District long street, Autumn Road, No. 2, 288, 2, Room 201 Applicant after: ZHEJIANG HEALTHFUTURE BIOMEDICAL TECHNOLOGY CO.,LTD. Address before: 310012 No. 388 Tong Road, Xihu District, Zhejiang, Hangzhou, Yuhang Applicant before: Chen Jinyang |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20171010 |
|
CF01 | Termination of patent right due to non-payment of annual fee |